ClinicalTrials.Veeva

Menu

Optimizing Medication Management by Older Adults Through the Med Wise Rx Community-based Program

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Completed

Conditions

Communication Research

Treatments

Behavioral: Med Wise Rx

Study type

Interventional

Funder types

Other

Identifiers

NCT05751980
2022-1605
Protocol Version 1/9/2024 (Other Identifier)
Pharmacy-Gen (Other Identifier)
A561000 (Other Identifier)

Details and patient eligibility

About

This study's overall goal is to enhance older adults' communication skills to access medication information and services to manage their medications safely and effectively. Med Wise Rx is an online 2-session program to improve communication skills for accessing medication information and services, leading to improved medication management. 160 adults age 65 years or older taking 4 or more medications will be on study for up to 9 months.

Full description

This study's overall goal is to enhance older adults' communication skills to access medication information and services to manage their medications safely and effectively. Older adults are 2-3 times more likely to experience adverse drug events (ADEs) which are linked to falls, morbidity, hospitalization, loss of independence and death. More complicated regimens, poor adherence and poor communication contribute to this greater risk.

The Med Wise Rx Program is an evidence-informed two-session interactive behavioral workshop that has been delivered in partnership with Aging and Disability Resource Centers (ADRCs) who informed the program design. This program was evaluated with 198 older adults in 8 Wisconsin counties and found a significant increase in participants' reported self-efficacy, communication skills and requests for medication checkups or comprehensive medication reviews (CMRs). There is a need for updating the Med Wise Rx program for dissemination virtually and to systematically examine the new design's effectiveness and implementation in organizations serving older adults.

The study team will conduct a Type 2 hybrid effectiveness-implementation study of Med Wise Rx delivered through a new technology-supported mode of education. A randomized patient to group treatment trial with a waitlist control group for older adults and/or caregivers aged 65 or older will be used. A mixed-methods approach will be used, incorporating surveys, observational data collection, and interviews. The RE-AIM Framework will guide and inform the processes. In collaboration with the Community Academic Aging Research Network (CAARN) and five community partners associated with 7 counties, this dissemination and implementation study will:

  • AIM 1. Refine strategies to disseminate and implement the Med Wise Rx communication program through enhanced digital delivery methods.
  • AIM 2. Develop a facilitator training program that maximizes Med Wise Rx delivery fidelity in its new format.
  • AIM 3. Evaluate the reach, effectiveness, adoption/ acceptability, implementation/ enactment, and maintenance of the Med Wise Rx program delivery by Aging and Disability Resource Centers (ADRCs) and participants at 8 weeks and 6 months post-delivery.

Protocol Amendment 1/31/24 to remove 6-month follow up time point for cohorts enrolled this spring.

Enrollment

121 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • community-dwelling
  • age 65 or older
  • use 4 or more medications
  • must have the cognitive ability to participate
  • speak and read English
  • be able to use a computer

Exclusion criteria

  • unable to attend either of the two Med Wise sessions (the first or the second, wait-listed control)
  • under age 65
  • unable to read/write English
  • taking fewer than 4 chronic medications
  • did not pass cognitive screener

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

121 participants in 2 patient groups

Med Wise Rx
Experimental group
Description:
An evidence-informed two-session interactive behavioral workshop. Participants will begin intervention within 3 weeks of enrollment.
Treatment:
Behavioral: Med Wise Rx
Waitlist Control
Active Comparator group
Description:
Participants will be crossed over to Med Wise Rx intervention up to 2 months after enrollment.
Treatment:
Behavioral: Med Wise Rx

Trial documents
1

Trial contacts and locations

4

Loading...

Central trial contact

Dale A Wilson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems